Multistate healthcare provider sued after halting some Medicare admissions

Listen
Text
  • Small
  • Medium
  • Large

A company that provides healthcare services to elderly patients in several states is facing a proposed securities class action alleging the Denver-based organization omitted key pieces of information from its initial public offering, resulting in its share price falling after Medicare admissions to one of its centers were banned, according to Law360

InnovAge operates more than a dozen healthcare centers in five states and manages the care of seniors who are eligible for both Medicare and Medicaid benefits. The lawsuit, filed Oct. 14 in Colorado federal court, alleges the company's stock price fell dramatically in September after it disclosed that CMS had suspended enrollment at one of its centers in Sacramento, Calif.

InnovAge completed its IPO in March, selling nearly 19 million shares of stock at a price of $21 per share. The company disclosed Sept. 21 that CMS suspended enrollment at one of its centers, and its stock price fell 25 percent to close at $8.75 per share Sept. 22. Shares were trading as low as $6.61 on Sept. 22, a 69 percent decline from the IPO price, the complaint alleges. 

The lawsuit alleges InnovAge violated securities laws by filing a registration statement with the Securities and Exchange Commission in February that was false and misleading. The registration statement omitted that some of the company's facilities failed to provide adequate services, and there was "significant risk that CMS would suspend new enrollments pending an audit of the company's services," the complaint states. 

The lawsuit claims that investors have suffered significant losses as a result of InnovAge's alleged misrepresentations and omissions. The lawsuit is seeking damages in favor of the proposed class members.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars